These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37204046)

  • 1. Exploiting Cancer Vulnerabilities by Blocking of the DHODH and GPX4 Pathways: A Multifunctional Bodipy/PROTAC Nanoplatform for the Efficient Synergistic Ferroptosis Therapy.
    Yao L; Yang N; Zhou W; Akhtar MH; Zhou W; Liu C; Song S; Li Y; Han W; Yu C
    Adv Healthc Mater; 2023 Oct; 12(26):e2300871. PubMed ID: 37204046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer.
    Mao C; Liu X; Zhang Y; Lei G; Yan Y; Lee H; Koppula P; Wu S; Zhuang L; Fang B; Poyurovsky MV; Olszewski K; Gan B
    Nature; 2021 May; 593(7860):586-590. PubMed ID: 33981038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A GPX4 non-enzymatic domain and MDM2 targeting peptide PROTAC for acute lymphoid leukemia therapy through ferroptosis induction.
    Niu F; Yang R; Feng H; Liu Y; Liu R; Ma B
    Biochem Biophys Res Commun; 2023 Dec; 684():149125. PubMed ID: 37897912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Warburg effect modulates DHODH role in ferroptosis: a review.
    Amos A; Amos A; Wu L; Xia H
    Cell Commun Signal; 2023 May; 21(1):100. PubMed ID: 37147673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative breast cancer.
    Zhou TJ; Zhang MM; Liu DM; Huang LL; Yu HQ; Wang Y; Xing L; Jiang HL
    Biomaterials; 2024 Mar; 305():122447. PubMed ID: 38154441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual degradation mechanism of GPX4 degrader in induction of ferroptosis exerting anti-resistant tumor effect.
    Wang C; Zheng C; Wang H; Shui S; Jin H; Liu G; Xu F; Liu Z; Zhang L; Sun D; Xu P
    Eur J Med Chem; 2023 Feb; 247():115072. PubMed ID: 36603510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manganese induces tumor cell ferroptosis through type-I IFN dependent inhibition of mitochondrial dihydroorotate dehydrogenase.
    Zhang S; Kang L; Dai X; Chen J; Chen Z; Wang M; Jiang H; Wang X; Bu S; Liu X; Zhang G; Tang H
    Free Radic Biol Med; 2022 Nov; 193(Pt 1):202-212. PubMed ID: 36228830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering Biodegradable Hollow Silica/Iron Composite Nanozymes for Breast Tumor Treatment through Activation of the "Ferroptosis Storm".
    Xue P; Zhuang H; Shao S; Bai T; Zeng X; Yan S
    ACS Nano; 2024 Sep; 18(37):25795-25812. PubMed ID: 39226614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DHODH tangoing with GPX4 on the ferroptotic stage.
    Wang F; Min J
    Signal Transduct Target Ther; 2021 Jun; 6(1):244. PubMed ID: 34145214
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitochondria-Targeted Prodrug Nanoassemblies for Efficient Ferroptosis-Based Therapy via Devastating Ferroptosis Defense Systems.
    Liu N; Lin Q; Huang Z; Liu C; Qin J; Yu Y; Chen W; Zhang J; Jiang M; Gao X; Huo S; Zhu X
    ACS Nano; 2024 Mar; 18(11):7945-7958. PubMed ID: 38452275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mitochondria-targeting DHODH inhibitor induces robust ferroptosis and alleviates immune suppression.
    Hai Y; Fan R; Zhao T; Lin R; Zhuang J; Deng A; Meng S; Hou Z; Wei G
    Pharmacol Res; 2024 Apr; 202():107115. PubMed ID: 38423231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of SOD2 enhances nasopharyngeal carcinoma cell radiosensitivity via ferroptosis induction modulated by DHODH inhibition.
    Amos A; Jiang N; Zong D; Gu J; Zhou J; Yin L; He X; Xu Y; Wu L
    BMC Cancer; 2023 Feb; 23(1):117. PubMed ID: 36737723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic Functional Nanomedicine Enhances Ferroptosis Therapy for Breast Tumors by a Blocking Defensive Redox System.
    Chen S; Yang J; Liang Z; Li Z; Xiong W; Fan Q; Shen Z; Liu J; Xu Y
    ACS Appl Mater Interfaces; 2023 Jan; 15(2):2705-2713. PubMed ID: 36622364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience.
    Lee J; Roh JL
    Cancer Lett; 2023 Apr; 559():216119. PubMed ID: 36893895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydroorotate dehydrogenase promotes cell proliferation and suppresses cell death in esophageal squamous cell carcinoma and colorectal carcinoma.
    Shi ZZ; Jin X; Li WT; Tao H; Song SJ; Fan ZW; Jiang W; Liang JW; Bai J
    Transl Cancer Res; 2023 Sep; 12(9):2294-2307. PubMed ID: 37859742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroorotate dehydrogenase regulates ferroptosis in neurons after spinal cord injury via the P53-ALOX15 signaling pathway.
    Li D; Lu X; Xu G; Liu S; Gong Z; Lu F; Xia X; Jiang J; Wang H; Zou F; Ma X
    CNS Neurosci Ther; 2023 Jul; 29(7):1923-1939. PubMed ID: 36942513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DHODH Inhibition Exerts Synergistic Therapeutic Effect with Cisplatin to Induce Ferroptosis in Cervical Cancer through Regulating mTOR Pathway.
    Jiang M; Song Y; Liu H; Jin Y; Li R; Zhu X
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy.
    Huang S; Le H; Hong G; Chen G; Zhang F; Lu L; Zhang X; Qiu Y; Wang Z; Zhang Q; Ouyang G; Shen J
    Acta Biomater; 2022 Aug; 148():244-257. PubMed ID: 35709941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4.
    Cai M; Ma F; Hu C; Li H; Cao F; Li Y; Dong J; Qin JJ
    Bioorg Med Chem; 2023 Jul; 90():117352. PubMed ID: 37257255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of ML210-Based glutathione peroxidase 4 (GPX4) degrader inducing ferroptosis of human cancer cells.
    Wang H; Wang C; Li B; Zheng C; Liu G; Liu Z; Zhang L; Xu P
    Eur J Med Chem; 2023 Jun; 254():115343. PubMed ID: 37087895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.